Envestnet Asset Management
DFTX

Envestnet Asset Management’s Definium Therapeutics DFTX Stock Holding History

Envestnet Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
+16,626
New +$411K ﹤0.01% 3778
2021
Q4 		– Sell
-2,935
Closed -$103K – 3918
2021
Q3 		$103K Buy
+2,935
New +$127K ﹤0.01% 3585

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Envestnet Asset Management's DFTX Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 16,626 shares worth $782K. The stake represents ﹤0.01% of the portfolio and ranks #3778 among its holdings. This is a return to the name: Envestnet Asset Management previously reported a position in DFTX as recently as Q3 2021.

Envestnet Asset Management first reported a position in DFTX in Q3 2021 and has held it in 2 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Envestnet Asset Management held 16,626 shares of Definium Therapeutics worth $782K as of Q2 2026.
  • Definium Therapeutics was a new Envestnet Asset Management position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3778 holding.
  • Envestnet Asset Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.